{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:40:44Z","timestamp":1792370444973,"version":"4.4.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":112,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000055","name":"U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["R01 DC022104"],"award-info":[{"award-number":["R01 DC022104"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS129554"],"award-info":[{"award-number":["R01 NS129554"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10587-0","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T02:35:55Z","timestamp":1782700555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["G\u03b1o\/z-biased coupling profile of the dopamine D3 receptor"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0139-3862","authenticated-orcid":false,"given":"Lucrezia","family":"Zanetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2845-2223","authenticated-orcid":false,"given":"Luca","family":"Franchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0036-4969","authenticated-orcid":false,"given":"Shirsha","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yini","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9090-2929","authenticated-orcid":false,"given":"Brian S.","family":"Muntean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4992-9350","authenticated-orcid":false,"given":"Cesare","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"10587_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10571-018-0632-3","volume":"39","author":"MO Klein","year":"2019","unstructured":"Klein, M. O. et al. Dopamine: Functions, signaling, and association with neurological diseases. Cell Mol. Neurobiol. 39, 31\u201359 (2019).","journal-title":"Cell Mol. Neurobiol."},{"key":"10587_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","volume":"78","author":"C Missale","year":"1998","unstructured":"Missale, C., Nash, S. R., Robinson, S. W., Jaber, M. & Caron, M. G. Dopamine receptors: From structure to function. Physiol. Rev. 78, 189\u2013225 (1998).","journal-title":"Physiol. Rev."},{"key":"10587_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/bph.12906","volume":"172","author":"JM Beaulieu","year":"2015","unstructured":"Beaulieu, J. M., Espinoza, S. & Gainetdinov, R. R. Dopamine receptors\u2014IUPHAR Review 13. Br. J. Pharm. 172, 1\u201323 (2015).","journal-title":"Br. J. Pharm."},{"key":"10587_CR4","doi-asserted-by":"publisher","first-page":"113173","DOI":"10.1016\/j.celrep.2023.113173","volume":"42","author":"I Masuho","year":"2023","unstructured":"Masuho, I. et al. Rules and mechanisms governing G protein coupling selectivity of GPCRs. Cell Rep. 42, 113173 (2023).","journal-title":"Cell Rep."},{"key":"10587_CR5","doi-asserted-by":"publisher","first-page":"e74101","DOI":"10.7554\/eLife.74101","volume":"11","author":"C Avet","year":"2022","unstructured":"Avet, C. et al. Effector membrane translocation biosensors reveal G protein and betaarrestin coupling profiles of 100 therapeutically relevant GPCRs. Elife 11, e74101 (2022).","journal-title":"Elife"},{"key":"10587_CR6","first-page":"102019","volume":"42","author":"V Burstrom","year":"2025","unstructured":"Burstrom, V. et al. A nanoluciferase complementation-based assay for monitoring beta-arrestin2 recruitment to the dopamine D(3) receptor. Biochem Biophys. Rep. 42, 102019 (2025).","journal-title":"Biochem Biophys. Rep."},{"key":"10587_CR7","doi-asserted-by":"crossref","unstructured":"Sanchez-Soto, M. et al. G protein-coupled receptor kinase 2 selectively enhances beta-arrestin recruitment to the D(2) dopamine receptor through mechanisms that are independent of receptor phosphorylation. Biomolecules 13 1552 (2023).","DOI":"10.3390\/biom13101552"},{"key":"10587_CR8","doi-asserted-by":"publisher","first-page":"34103","DOI":"10.1074\/jbc.M109.055707","volume":"284","author":"Y Namkung","year":"2009","unstructured":"Namkung, Y., Dipace, C., Urizar, E., Javitch, J. A. & Sibley, D. R. G protein-coupled receptor kinase-2 constitutively regulates D2 dopamine receptor expression and signaling independently of receptor phosphorylation. J. Biol. Chem. 284, 34103\u201334115 (2009).","journal-title":"J. Biol. Chem."},{"key":"10587_CR9","doi-asserted-by":"publisher","first-page":"15038","DOI":"10.1074\/jbc.M900388200","volume":"284","author":"Y Namkung","year":"2009","unstructured":"Namkung, Y., Dipace, C., Javitch, J. A. & Sibley, D. R. G protein-coupled receptor kinase-mediated phosphorylation regulates post-endocytic trafficking of the D2 dopamine receptor. J. Biol. Chem. 284, 15038\u201315051 (2009).","journal-title":"J. Biol. Chem."},{"key":"10587_CR10","doi-asserted-by":"publisher","first-page":"106223","DOI":"10.1016\/j.phrs.2022.106223","volume":"179","author":"W Xu","year":"2022","unstructured":"Xu, W., Bearoff, F. & Kortagere, S. G-protein biased signaling agonists of Dopamine D3 receptor promote distinct activation patterns of ERK1\/2. Pharm. Res 179, 106223 (2022).","journal-title":"Pharm. Res"},{"key":"10587_CR11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.biopsych.2023.03.006","volume":"94","author":"S Schamiloglu","year":"2023","unstructured":"Schamiloglu, S. et al. Arrestin-3 agonism at dopamine D(3) receptors defines a subclass of second-generation antipsychotics that promotes drug tolerance. Biol. Psychiatry 94, 531\u2013542 (2023).","journal-title":"Biol. Psychiatry"},{"key":"10587_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1124\/pr.118.016790","volume":"71","author":"T Kenakin","year":"2019","unstructured":"Kenakin, T. Biased receptor signaling in drug discovery. Pharm. Rev. 71, 267\u2013315 (2019).","journal-title":"Pharm. Rev."},{"key":"10587_CR13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1124\/jpet.110.173948","volume":"336","author":"T Kenakin","year":"2011","unstructured":"Kenakin, T. Functional selectivity and biased receptor signaling. J. Pharm. Exp. Ther. 336, 296\u2013302 (2011).","journal-title":"J. Pharm. Exp. Ther."},{"key":"10587_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.106.104463","volume":"320","author":"JD Urban","year":"2007","unstructured":"Urban, J. D. et al. Functional selectivity and classical concepts of quantitative pharmacology. J. Pharm. Exp. Ther. 320, 1\u201313 (2007).","journal-title":"J. Pharm. Exp. Ther."},{"key":"10587_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd3954","volume":"12","author":"T Kenakin","year":"2013","unstructured":"Kenakin, T. & Christopoulos, A. Signalling bias in new drug discovery: detection, quantification and therapeutic impact. Nat. Rev. Drug Discov. 12, 205\u2013216 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"key":"10587_CR16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.chembiol.2021.07.004","volume":"29","author":"E Von Moo","year":"2022","unstructured":"Von Moo, E. et al. Ligand-directed bias of G protein signaling at the dopamine D(2) receptor. Cell Chem. Biol. 29, 226\u2013238. e224 (2022).","journal-title":"Cell Chem. Biol."},{"key":"10587_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1124\/molpharm.123.000722","volume":"104","author":"R Alabdali","year":"2023","unstructured":"Alabdali, R., Franchini, L. & Orlandi, C. Galpha protein signaling bias at serotonin 1A receptor. Mol. Pharm. 104, 230\u2013238 (2023).","journal-title":"Mol. Pharm."},{"key":"10587_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31652-2","volume":"13","author":"MJ Wall","year":"2022","unstructured":"Wall, M. J. et al. Selective activation of Galphaob by an adenosine A(1) receptor agonist elicits analgesia without cardiorespiratory depression. Nat. Commun. 13, 4150 (2022).","journal-title":"Nat. Commun."},{"key":"10587_CR19","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1111\/bph.16388","volume":"182","author":"D Reiner-Link","year":"2025","unstructured":"Reiner-Link, D., Madsen, J. S., Gloriam, D. E., Brauner-Osborne, H. & Hauser, A. S. Differential G protein activation by the long and short isoforms of the dopamine D(2) receptor. Br. J. Pharm. 182, 3336\u20133352 (2025).","journal-title":"Br. J. Pharm."},{"key":"10587_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01771-3","volume":"12","author":"J Cabana-Dominguez","year":"2022","unstructured":"Cabana-Dominguez, J., Torrico, B., Reif, A., Fernandez-Castillo, N. & Cormand, B. Comprehensive exploration of the genetic contribution of the dopaminergic and serotonergic pathways to psychiatric disorders. Transl. Psychiatry 12, 11 (2022).","journal-title":"Transl. Psychiatry"},{"key":"10587_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/FBP.0b013e3283242f05","volume":"20","author":"B Le Foll","year":"2009","unstructured":"Le Foll, B., Gallo, A., Le Strat, Y., Lu, L. & Gorwood, P. Genetics of dopamine receptors and drug addiction: A comprehensive review. Behav. Pharm. 20, 1\u201317 (2009).","journal-title":"Behav. Pharm."},{"key":"10587_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-017-0071-9","volume":"8","author":"JP Kesby","year":"2018","unstructured":"Kesby, J. P., Eyles, D. W., McGrath, J. J. & Scott, J. G. Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience. Transl. Psychiatry 8, 30 (2018).","journal-title":"Transl. Psychiatry"},{"key":"10587_CR23","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/mp.2017.16","volume":"22","author":"AH Ashok","year":"2017","unstructured":"Ashok, A. H. et al. The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment. Mol. Psychiatry 22, 666\u2013679 (2017).","journal-title":"Mol. Psychiatry"},{"key":"10587_CR24","doi-asserted-by":"publisher","first-page":"1492126","DOI":"10.3389\/fpsyt.2024.1492126","volume":"15","author":"HJ MacDonald","year":"2024","unstructured":"MacDonald, H. J., Kleppe, R., Szigetvari, P. D. & Haavik, J. The dopamine hypothesis for ADHD: An evaluation of evidence accumulated from human studies and animal models. Front Psychiatry 15, 1492126 (2024).","journal-title":"Front Psychiatry"},{"key":"10587_CR25","doi-asserted-by":"publisher","first-page":"110133","DOI":"10.1016\/j.neuropharm.2024.110133","volume":"260","author":"H Chen","year":"2024","unstructured":"Chen, H. et al. Dopaminergic system and neurons: Role in multiple neurological diseases. Neuropharmacology 260, 110133 (2024).","journal-title":"Neuropharmacology"},{"key":"10587_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1124\/jpet.107.134296","volume":"325","author":"JR Lane","year":"2008","unstructured":"Lane, J. R., Powney, B., Wise, A., Rees, S. & Milligan, G. G protein coupling and ligand selectivity of the D2L and D3 dopamine receptors. J. Pharm. Exp. Ther. 325, 319\u2013330 (2008).","journal-title":"J. Pharm. Exp. Ther."},{"key":"10587_CR27","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1021\/acsptsci.3c00339","volume":"7","author":"D Monnich","year":"2024","unstructured":"Monnich, D. et al. Activation of Multiple G Protein Pathways to Characterize the Five Dopamine Receptor Subtypes Using Bioluminescence Technology. ACS Pharm. Transl. Sci. 7, 834\u2013854 (2024).","journal-title":"ACS Pharm. Transl. Sci."},{"key":"10587_CR28","unstructured":"Olsen, R. H. J. Development of Next-generation G Protein Biosensors for Deconvoluting the Complexity of GPCR Signaling, The University of North Carolina at Chapel Hill, (2019)."},{"key":"10587_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51993-4","volume":"15","author":"S Arroyo-Urea","year":"2024","unstructured":"Arroyo-Urea, S. et al. A bitopic agonist bound to the dopamine 3 receptor reveals a selectivity site. Nat. Commun. 15, 7759 (2024).","journal-title":"Nat. Commun."},{"key":"10587_CR30","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.molcel.2021.01.003","volume":"81","author":"P Xu","year":"2021","unstructured":"Xu, P. et al. Structures of the human dopamine D3 receptor-G(i) complexes. Mol. Cell 81, 1147\u20131159. e1144 (2021).","journal-title":"Mol. Cell"},{"key":"10587_CR31","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1124\/mol.115.101808","volume":"89","author":"M Sanchez-Soto","year":"2016","unstructured":"Sanchez-Soto, M. et al. Evidence for noncanonical neurotransmitter activation: Norepinephrine as a dopamine D2-like receptor agonist. Mol. Pharm. 89, 457\u2013466 (2016).","journal-title":"Mol. Pharm."},{"key":"10587_CR32","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/bph.12988","volume":"172","author":"M Wood","year":"2015","unstructured":"Wood, M., Dubois, V., Scheller, D. & Gillard, M. Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors. Br. J. Pharm. 172, 1124\u20131135 (2015).","journal-title":"Br. J. Pharm."},{"key":"10587_CR33","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41422-023-00808-0","volume":"33","author":"P Xu","year":"2023","unstructured":"Xu, P. et al. Structural genomics of the human dopamine receptor system. Cell Res 33, 604\u2013616 (2023).","journal-title":"Cell Res"},{"key":"10587_CR34","doi-asserted-by":"publisher","first-page":"5526","DOI":"10.1021\/acs.jmedchem.0c00424","volume":"63","author":"AE Moritz","year":"2020","unstructured":"Moritz, A. E. et al. Discovery, optimization, and characterization of ML417: A novel and highly selective D(3) dopamine receptor agonist. J. Med Chem. 63, 5526\u20135567 (2020).","journal-title":"J. Med Chem."},{"key":"10587_CR35","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/363274a0","volume":"363","author":"BR Conklin","year":"1993","unstructured":"Conklin, B. R., Farfel, Z., Lustig, K. D., Julius, D. & Bourne, H. R. Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha. Nature 363, 274\u2013276 (1993).","journal-title":"Nature"},{"key":"10587_CR36","doi-asserted-by":"publisher","first-page":"12054","DOI":"10.1073\/pnas.1905993116","volume":"116","author":"N Okashah","year":"2019","unstructured":"Okashah, N. et al. Variable G protein determinants of GPCR coupling selectivity. Proc. Natl. Acad. Sci. USA 116, 12054\u201312059 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10587_CR37","doi-asserted-by":"publisher","first-page":"17929","DOI":"10.1074\/jbc.M116.735720","volume":"291","author":"A Semack","year":"2016","unstructured":"Semack, A., Sandhu, M., Malik, R. U., Vaidehi, N. & Sivaramakrishnan, S. Structural elements in the galphas and Galphaq C termini that mediate selective G protein-coupled receptor (GPCR) signaling. J. Biol. Chem. 291, 17929\u201317940 (2016).","journal-title":"J. Biol. Chem."},{"key":"10587_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33851-3","volume":"13","author":"LH Zhao","year":"2022","unstructured":"Zhao, L. H. et al. Structure insights into selective coupling of G protein subtypes by a class B G protein-coupled receptor. Nat. Commun. 13, 6670 (2022).","journal-title":"Nat. Commun."},{"key":"10587_CR39","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature10867","volume":"482","author":"AC Kruse","year":"2012","unstructured":"Kruse, A. C. et al. Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature 482, 552\u2013556 (2012).","journal-title":"Nature"},{"key":"10587_CR40","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41586-023-05789-z","volume":"615","author":"F Sadler","year":"2023","unstructured":"Sadler, F. et al. Autoregulation of GPCR signalling through the third intracellular loop. Nature 615, 734\u2013741 (2023).","journal-title":"Nature"},{"key":"10587_CR41","doi-asserted-by":"publisher","first-page":"11956","DOI":"10.1073\/pnas.1820944116","volume":"116","author":"M Sandhu","year":"2019","unstructured":"Sandhu, M. et al. Conformational plasticity of the intracellular cavity of GPCR-G-protein complexes leads to G-protein promiscuity and selectivity. Proc. Natl. Acad. Sci. USA 116, 11956\u201311965 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10587_CR42","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.bbamcr.2018.06.001","volume":"1865","author":"N Sun","year":"2018","unstructured":"Sun, N. et al. Molecular mechanisms involved in epidermal growth factor receptor-mediated inhibition of dopamine D(3) receptor signaling. Biochim Biophys. Acta Mol. Cell Res 1865, 1187\u20131200 (2018).","journal-title":"Biochim Biophys. Acta Mol. Cell Res"},{"key":"10587_CR43","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/cne.20953","volume":"496","author":"A Visel","year":"2006","unstructured":"Visel, A., Alvarez-Bolado, G., Thaller, C. & Eichele, G. Comprehensive analysis of the expression patterns of the adenylate cyclase gene family in the developing and adult mouse brain. J. Comp. Neurol. 496, 684\u2013697 (2006).","journal-title":"J. Comp. Neurol."},{"key":"10587_CR44","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.celrep.2017.12.022","volume":"22","author":"BS Muntean","year":"2018","unstructured":"Muntean, B. S. et al. Interrogating the spatiotemporal landscape of neuromodulatory GPCR signaling by real-time imaging of cAMP in intact neurons and circuits. Cell Rep. 22, 255\u2013268 (2018).","journal-title":"Cell Rep."},{"key":"10587_CR45","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/S0092-8674(00)81826-7","volume":"87","author":"JZ Tsien","year":"1996","unstructured":"Tsien, J. Z. et al. Subregion- and cell type-restricted gene knockout in mouse brain. Cell 87, 1317\u20131326 (1996).","journal-title":"Cell"},{"key":"10587_CR46","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/j.1476-5381.1996.tb16063.x","volume":"119","author":"BJ Bowery","year":"1996","unstructured":"Bowery, B. J. et al. Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626. Br. J. Pharm. 119, 1491\u20131497 (1996).","journal-title":"Br. J. Pharm."},{"key":"10587_CR47","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1021\/jm049465g","volume":"48","author":"P Grundt","year":"2005","unstructured":"Grundt, P. et al. Novel heterocyclic trans olefin analogues of N-4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butylarylcarboxamides as selective probes with high affinity for the dopamine D3 receptor. J. Med Chem. 48, 839\u2013848 (2005).","journal-title":"J. Med Chem."},{"key":"10587_CR48","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/S0960-894X(98)00469-7","volume":"8","author":"J Yuan","year":"1998","unstructured":"Yuan, J. et al. NGB 2904 and NGB 2849: Two highly selective dopamine D3 receptor antagonists. Bioorg. Med Chem. Lett. 8, 2715\u20132718 (1998).","journal-title":"Bioorg. Med Chem. Lett."},{"key":"10587_CR49","doi-asserted-by":"publisher","first-page":"108718","DOI":"10.1016\/j.celrep.2021.108718","volume":"34","author":"BS Muntean","year":"2021","unstructured":"Muntean, B. S. et al. Galphao is a major determinant of cAMP signaling in the pathophysiology of movement disorders. Cell Rep. 34, 108718 (2021).","journal-title":"Cell Rep."},{"key":"10587_CR50","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41589-022-01231-z","volume":"19","author":"W Jang","year":"2023","unstructured":"Jang, W., Lu, S., Xu, X., Wu, G. & Lambert, N. A. The role of G protein conformation in receptor-G protein selectivity. Nat. Chem. Biol. 19, 687\u2013694 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"10587_CR51","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1152\/physrev.00003.2005","volume":"85","author":"N Wettschureck","year":"2005","unstructured":"Wettschureck, N. & Offermanns, S. Mammalian G proteins and their cell type specific functions. Physiol. Rev. 85, 1159\u20131204 (2005).","journal-title":"Physiol. Rev."},{"key":"10587_CR52","doi-asserted-by":"publisher","first-page":"110446","DOI":"10.1016\/j.jbc.2025.110446","volume":"301","author":"NL Momplaisir","year":"2025","unstructured":"Momplaisir, N. L., Chandan, N. R., Wang, B., Qu, E. & Smrcka, A. V. GoLoco\/GPR motif-dependent regulation of Rap1GAP1 by galpha(o) is disrupted by galpha(o) encephalopathy variants. J. Biol. Chem. 301, 110446 (2025).","journal-title":"J. Biol. Chem."},{"key":"10587_CR53","doi-asserted-by":"publisher","first-page":"eabi9869","DOI":"10.1126\/scisignal.abi9869","volume":"15","author":"NR Chandan","year":"2022","unstructured":"Chandan, N. R., Abraham, S., SenGupta, S., Parent, C. A. & Smrcka, A. V. A network of Galpha(i) signaling partners is revealed by proximity labeling proteomics analysis and includes PDZ-RhoGEF. Sci. Signal 15, eabi9869 (2022).","journal-title":"Sci. Signal"},{"key":"10587_CR54","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00213-007-0888-7","volume":"195","author":"M van den Buuse","year":"2007","unstructured":"van den Buuse, M., Martin, S., Holgate, J., Matthaei, K. & Hendry, I. Mice deficient in the alpha subunit of G(z) show changes in pre-pulse inhibition, anxiety and responses to 5-HT(1A) receptor stimulation, which are strongly dependent on the genetic background. Psychopharmacol. (Berl.) 195, 273\u2013283 (2007).","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10587_CR55","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1073\/pnas.051632598","volume":"98","author":"M Jiang","year":"2001","unstructured":"Jiang, M., Spicher, K., Boulay, G., Wang, Y. & Birnbaumer, L. Most central nervous system D2 dopamine receptors are coupled to their effectors by Go. Proc. Natl. Acad. Sci. USA 98, 3577\u20133582 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10587_CR56","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.neuropharm.2003.11.024","volume":"46","author":"KJ Leck","year":"2004","unstructured":"Leck, K. J. et al. Deletion of guanine nucleotide binding protein alpha z subunit in mice induces a gene dose dependent tolerance to morphine. Neuropharmacology 46, 836\u2013846 (2004).","journal-title":"Neuropharmacology"},{"key":"10587_CR57","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3390\/biomedicines9030314","volume":"9","author":"K Lanza","year":"2021","unstructured":"Lanza, K. & Bishop, C. Dopamine D3 receptor plasticity in Parkinson\u2019s disease and L-DOPA-induced dyskinesia. Biomedicines 9, 314 (2021).","journal-title":"Biomedicines"},{"key":"10587_CR58","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2174\/187152706784111551","volume":"5","author":"P Sokoloff","year":"2006","unstructured":"Sokoloff, P. et al. The dopamine D3 receptor: A therapeutic target for the treatment of neuropsychiatric disorders. CNS Neurol. Disord. Drug Targets 5, 25\u201343 (2006).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10587_CR59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0014-2999(97)01179-5","volume":"335","author":"RA Durham","year":"1997","unstructured":"Durham, R. A., Eaton, M. J., Moore, K. E. & Lookingland, K. J. Effects of selective activation of dopamine D2 and D3 receptors on prolactin secretion and the activity of tuberoinfundibular dopamine neurons. Eur. J. Pharm. 335, 37\u201342 (1997).","journal-title":"Eur. J. Pharm."},{"key":"10587_CR60","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1124\/jpet.105.084202","volume":"314","author":"RB McCall","year":"2005","unstructured":"McCall, R. B., Lookingland, K. J., Bedard, P. J. & Huff, R. M. Sumanirole, a highly dopamine D2-selective receptor agonist: In vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson\u2019s disease. J. Pharm. Exp. Ther. 314, 1248\u20131256 (2005).","journal-title":"J. Pharm. Exp. Ther."},{"key":"10587_CR61","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1021\/acs.jmedchem.5b01612","volume":"59","author":"MF Zou","year":"2016","unstructured":"Zou, M. F. et al. Novel analogues of (R)-5-(Methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (sumanirole) provide clues to dopamine D2\/D3 receptor agonist selectivity. J. Med Chem. 59, 2973\u20132988 (2016).","journal-title":"J. Med Chem."},{"key":"10587_CR62","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1002\/cmdc.201402398","volume":"9","author":"J Chen","year":"2014","unstructured":"Chen, J. et al. Pramipexole derivatives as potent and selective dopamine D(3) receptor agonists with improved human microsomal stability. ChemMedChem 9, 2653\u20132660 (2014).","journal-title":"ChemMedChem"},{"key":"10587_CR63","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1001\/archneurol.2009.32","volume":"66","author":"CCI Parkinson Study Group","year":"2009","unstructured":"Parkinson Study Group, C. C. I. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease. Arch. Neurol. 66, 563\u2013570 (2009).","journal-title":"Arch. Neurol."},{"key":"10587_CR64","first-page":"1931","volume":"284","author":"G Parkinson Study","year":"2000","unstructured":"Parkinson Study, G. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Park. Study Group. JAMA 284, 1931\u20131938 (2000).","journal-title":"Park. Study Group. JAMA"},{"key":"10587_CR65","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s42003-023-04465-2","volume":"6","author":"Y Ono","year":"2023","unstructured":"Ono, Y. et al. Generation of Galphai knock-out HEK293 cells illuminates Galphai-coupling diversity of GPCRs. Commun. Biol. 6, 112 (2023).","journal-title":"Commun. Biol."},{"key":"10587_CR66","doi-asserted-by":"publisher","first-page":"e2406686121","DOI":"10.1073\/pnas.2406686121","volume":"121","author":"Y Liao","year":"2024","unstructured":"Liao, Y. & Muntean, B. S. KCTD1 regulation of Adenylyl cyclase type 5 adjusts striatal cAMP signaling. Proc. Natl. Acad. Sci. USA 121, e2406686121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10587_CR67","doi-asserted-by":"publisher","first-page":"e3003117","DOI":"10.1371\/journal.pbio.3003117","volume":"23","author":"DC Sloan","year":"2025","unstructured":"Sloan, D. C., Liao, Y., Ray, F. & Muntean, B. S. The G protein modifier KCTD5 tunes the decoding of neuromodulatory signals necessary for motor function in striatal neurons. PLoS Biol. 23, e3003117 (2025).","journal-title":"PLoS Biol."},{"key":"10587_CR68","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1177\/00236772231169550","volume":"57","author":"MJ Bodnar","year":"2023","unstructured":"Bodnar, M. J., Ratuski, A. S. & Weary, D. M. Mouse isoflurane anesthesia using the drop method. Lab Anim. 57, 623\u2013630 (2023).","journal-title":"Lab Anim."},{"key":"10587_CR69","doi-asserted-by":"publisher","first-page":"e0474242025","DOI":"10.1523\/JNEUROSCI.0474-24.2025","volume":"45","author":"CE Cryan","year":"2025","unstructured":"Cryan, C. E. et al. Bmal1 modulates striatal cAMP signaling and motor learning. J. Neurosci. 45, e0474242025 (2025).","journal-title":"J. Neurosci."},{"key":"10587_CR70","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1126\/science.adp9833","volume":"389","author":"AG Yee","year":"2025","unstructured":"Yee, A. G., Liao, Y., Muntean, B. S. & Ford, C. P. Discrete spatiotemporal encoding of striatal dopamine transmission. Science 389, 200\u2013206 (2025).","journal-title":"Science"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10587-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10587-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10587-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:02:43Z","timestamp":1792368163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10587-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10587"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10587-0","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"2 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1365"}}